Artificial Heart

This channel includes news and new technology innovations for total artificial hearts (TAH). These technologies are used in cardiovascular surgery to temporarily or permanently replace the heart in advanced heart failure patients.

News | Artificial Heart

February 10, 2021 - The U.S. Food and Drug Administration (FDA) has granted artificial heart developer Carmat approval ...

Home February 10, 2021
Home
News | Heart Failure

December 2, 2020 — The Centers for Medicare and Medicaid Services (CMS) finalized updates to Medicare coverage policies ...

Home December 02, 2020
Home
The Medtronic Heartware and Abbott Heartmate 3 LVADs and others currently cleared by the FDA might be easier to use in Medicare advanced heart failure patients under new guidelines proposed by CMS. Photo by Dave Fornell
Feature | Heart Failure | Dave Fornell, Editor

August 21, 2020 — The U.S. Centers for Medicare and Medicaid Services (CMS) proposed updates to coverage policies for to ...

Home August 21, 2020
Home
News | Artificial Heart

May 27, 2020 — Carmat, a developer of the of a next generation advanced total artificial heart, announces the first ...

Home May 27, 2020
Home
News | Artificial Heart

March 10, 2020 —  The U.S. Food and Drug Administration (FDA) has cleared the SynCardia Systems 50cc temporary Total ...

Home March 10, 2020
Home
News | Heart Failure

March 5, 2020 — Abbott recently received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA ...

Home March 05, 2020
Home
News | Heart Failure

February 12, 2020 — The U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device exemption ...

Home February 12, 2020
Home
News | Atrial Fibrillation

May 13, 2019 — A randomized clinical trial effectively used nerve stimulation through an ear clip to reduce atrial ...

Home May 13, 2019
Home
News | Cardiovascular Surgery

December 11, 2018 — The scientific journal Nature recently published an article from Munich University Hospital which ...

Home December 11, 2018
Home
A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.
Feature | Heart Failure

October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S ...

Home October 19, 2018
Home
News | Hemodynamic Support Devices

January 25, 2018 – According to the latest market study released by Technavio, the global circulatory support devices ...

Home January 25, 2018
Home
News | Artificial Heart

December 11, 2017 — CorInnova Inc. recently announced it was awarded second prize in the “2017 InnoSTARS” life science ...

Home December 11, 2017
Home
News | Artificial Heart

October 27, 2017 — CorInnova Inc. announced it has received notice of allowance of a seminal patent to protect its ...

Home October 27, 2017
Home
Technology | Ventricular Assist Devices (VAD)

August 29, 2017 — Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev ...

Home August 29, 2017
Home
News | Ventricular Assist Devices (VAD)

December 8, 2016 — St. Jude Medical Inc. announced results of the MOMENTUM 3 U.S. IDE Clinical Study during a late ...

Home December 08, 2016
Home
Subscribe Now